EndoGastric Solutions Announces New Data at Digestive Disease Week 2018 Supporting the Durability and Efficacy of TIF 2.0 Procedure for GERD Patients »
June 2, 2018
TIF 2.0 procedure provides improved quality of life and elimination of daily PPI use for up to 10 years in patients with symptomatic GERD; TIF 2.0 procedure combined with laparoscopic hiatal hernia repair is a safe and effective option for patients with severe GERD and hiatal hernia REDMOND, Wash – EndoGastric® Solutions today announced the […] More »
EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients »
May 31, 2018
TIF Procedure offers excellent short and long-term relief for the majority of chronic GERD patients. REDMOND, Wash – EndoGastric® Solutions today announced the publication of a meta-analysis supporting the clinical utility of Transoral Incisionless Fundoplication (TIF®) 2.0 in the treatment of refractory gastroesophageal reflux disease (GERD). The TIF 2.0 procedure is a minimally invasive endoscopic option […] More »
EndoGastric Solutions Announces Publication of 5 Year TEMPO Data Confirming Lasting Improvement of GERD Symptoms with TIF 2.0 Procedure »
February 7, 2018
Cost comparison analysis indicates significantly lower healthcare utilization by TIF procedure patients REMOND, Wash. – EndoGastric® Solutions today announced that Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training has published five year follow-up data focused on control of GERD symptoms and healthcare economics after a Transoral Incisionless Fundoplication (TIF®) 2.0 procedure in […] More »
EndoGastric Solutions announces 100 Million Lives Now Covered for Transoral Incisionless Fundoplication Procedure »
January 4, 2018
Policy decisions by federal and commercial payers have expanded coverage for the TIF 2.0 procedure in 2018, extending access to effective long-term control of acid reflux symptoms REDMOND, Wash. – Federal and commercial payer plans responsible for over 100 million lives have recognized the value of EndoGastric Solutions’ TIF 2.0 procedure for gastroesophageal reflux disease (GERD) […] More »
- 1
- 2
- 3
- …
- 15
- Next Page »